BMRN - Biomarin Pharmaceutical Inc. - Registered Shares
IEX Last Trade
91.17
-0.200 -0.219%
Share volume: 1,369,401
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$91.37
-0.20
-0.22%
Summary score
24%
Profitability
14%
Dept financing
14%
Liquidity
45%
Performance
31%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
1.62%
Return on assets
0.02%
Return on sales
-0.44%
Return on invested capital
2.58%
Total debt ratio
28.87%
Debt ratio change over timeo
-205.73%
Current Ratio
4.26%
Quick Ratio
2.9%
Cash Position Ratio
1.87%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
1.04%
Return on assets
0.66%
Return on sales
7.15%
Return on invested capital
1.83%
Total debt ratio
27.12%
Debt ratio change over timeo
18.03%
Current Ratio
3.18%
Quick Ratio
2.06%
Cash Position Ratio
1.2%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
1.75%
Return on assets
1.14%
Return on sales
12.09%
Return on invested capital
3.17%
Total debt ratio
26.17%
Debt ratio change over time
33.79%
Current Ratio
2.74%
Quick Ratio
1.7%
Cash Position Ratio
0.96%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-134.26%
Return on assets
206.95%
Return on sales
3484.68%
Return on invested capital
-152.14%
Total debt ratio
-20572.62%
Debt ratio change over time
-205.73%
Current Ratio
-3473.72%
Quick Ratio
-2347.89%
Cash Position Ratio
-1641.71%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BMRN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 1.62% | 13.79% | 34.47% | 7.43% |
| Return on assets | 0.02% | 2.76% | 3.15% | 5.62% |
| Return on sales | -0.44% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 2.58% | 2.36% | 5.39% | 19.77% |
| Profitability | 4% | 43% | 66% | 80% |
| Total debt ratio | 28.87% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -205.73% | 308.97% | -6.99% | 1.18% |
| Dept financing | 8% | 50% | 25% | 7% |
| Current Ratio | 3.18% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.06% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.2% | 0.36% | 1.28% | 2.93% |
| Liquididy | 66% | 14% | 33% | 75% |
| Short-term ratios | BMRN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 1.04% | 13.77% | 13.25% | 3.8% |
| Return on assets | 0.66% | 2.43% | 1.89% | 3.09% |
| Return on sales | 7.15% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 1.83% | 2.14% | 3.39% | 9.18% |
| Profitability | 18% | 71% | 68% | 82% |
| Total debt ratio | 27.12% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | 18.03% | 46.38% | -72.08% | 1.51% |
| Dept financing | 17% | 50% | 25% | 7% |
| Current Ratio | 3.18% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.06% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.2% | 0.36% | 1.28% | 2.93% |
| Liquididy | 36% | 12% | 31% | 75% |